FDA discusses track and trace; Aesica plant offers serialization for Chinese market;

> The FDA discusses its efforts on track and trace. Blog Post

> Authorities in Philippines have recalled a batch of Cefuroxime manufactured by Flamingo Pharmaceuticals saying testing showed it did not meet potency requirements. Report

> A U.S. official says trying to keep track of Chinese APIs is hopeless. Story

> CDMO Aesica is providing and commercial production of two anti-allergy product lines for the Chinese market at its site in Pianezza, Italy. Release

And Finally... The inability of Ranbaxy Laboratories to get its first-to-file copy of the Novartis ($NVS) heart drug Diovan to market has added about $900 million to U.S. consumers' drug costs. Story